Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Other 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Opioid-Induced Constipation 1Cancer Pain 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Lidocaine 2Injections 2Docosahexaenoic Acids 2Diet 2sibutramine 1polyethylene glycol 3350 1oxycodone-acetaminophen 1naloxegol 1naldemedine 1methylnaltrexone 1Ursodeoxycholic Acid 1Tramadol 1Topiramate 1Solutions 1Sennosides 1Resistance Training 1Quality of Life 1Propofol 1Progestins 1Polyethylene Glycols 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Oxycodone × Other × Clear all
NCT06897917 2025-03-27

Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain

Henan Cancer Hospital

Phase 4 Not yet recruiting
203 enrolled
Other

Cancer Pain, Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡